|
AZD1390 Clinical Trials
2 actively recruiting trials across 1 location
▼ -1 trial since July 2026
Also known as: ATM inhibitor
Pipeline
Phase 1: 1Phase 2/3: 1
Top Sponsors
- University of Leeds1
- Global Coalition for Adaptive Research1
Indications
- Cancer2
- Glioblastoma1
- Lung Cancer1
- Non Small Cell Lung Cancer1
Other1 trial
Birmingham, Alabama1 trial
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
University of Alabama at Birmingham
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.